DJIA 17,698.18 -77.94 -0.44%
NASDAQ 4,880.23 -20.66 -0.42%
S&P 500 2,059.69 -8.20 -0.40%
market minute promo

PHARMACYCLICS, INC. (NASDAQ: PCYC)

255.09 -0.86 (-0.34%)

REAL-TIME: Last trade at

Extended Hours: $255.09 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PCYC $255.09 -0.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $255.79
Previous Close $255.95
Daily Range $254.64 - $256.25
52-Week Range $82.51 - $258.95
Market Cap $19.4B
P/E Ratio 232.68
Dividend (Yield) $0.00 (0.0%)
Volume 1,124,622
Average Daily Volume 2,309,259
Current FY EPS $0.26

Sector

Healthcare

Industry

Drug Makers

PHARMACYCLICS, INC. (PCYC) Description

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website: http://www.pharmacyclics.com/

News & Commentary

Better Dividend Stock: AbbVie or Gilead Sciences, Inc.?

AbbVie and Gilead are two closely followed dividend stocks in the healthcare sector. Which one offers investors the better long-term prospects moving forward?

Solid Tumor Study Investigating Ibrutinib in Combination with Anti-PD-L1 Antibody Commences in Patie

Solid Tumor Study Investigating Ibrutinib in Combination with Anti-PD-L1 Antibody Commences in Patients

Pharmacyclics, BioMarin, And Incyte: A Quick Screen

New ETF From BlackRock And Edelman

New ETF From BlackRock And Edelman

3 Stocks Reiterated As A Hold: PCYC, LNKD, PM

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

Confessions of a Value Investor Stuck in a High-Growth Industry

It's OK to buy premium-priced biotechs.

The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releas

The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases

Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog

See More PCYC News...

PCYC's Top Competitors

PCYC $255.09 (-0.34%)
Current stock: PCYC
AMGN $157.10 (-1.72%)
Current stock: AMGN
GILD $97.72 (-0.42%)
Current stock: GILD
BIIB $413.81 (-2.00%)
Current stock: BIIB